Search Results - "Stobbione, Paolo"
-
1
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Published in The Journal of infection (01-08-2020)“…•Baricitinib at 4 mg/day/orally was given to 12 patients with moderate COVID-19.•In baricitinib-treated patients no adverse events were recorded, after 2…”
Get full text
Journal Article -
2
SARS‐CoV‐2 infection as a trigger of autoimmune response
Published in Clinical and translational science (01-05-2021)“…Currently, few evidences have shown the possible involvement of autoimmunity in patients affected by coronavirus disease 2019 (COVID‐19). In this study, we…”
Get full text
Journal Article -
3
Organizational determinants of hospital stay: establishing the basis of a widespread action on more efficient pathways in medical units
Published in Internal and emergency medicine (01-09-2020)“…Given the high hospital costs, the increasing clinical complexity and the overcrowding of emergency departments, it is crucial to improve the efficiency of…”
Get full text
Journal Article -
4
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Published in The Journal of infection (01-10-2020)“…•Baricitinib, an anti-JAK1/JAK2, reduces cytokine release and SARS-Co-V2 entry.•In a retrospective multicenter study baricitinib reduces COVID-19 mortality…”
Get full text
Journal Article -
5
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors
Published in Journal of autoimmunity (01-03-2020)“…Alveolar haemorrhage (AH) is considered an important cause of morbidity and early mortality in anti-neutrophil cytoplasmic antibodies (ANCA)-associated…”
Get full text
Journal Article -
6
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study
Published in Clinical and experimental rheumatology (01-03-2021)“…We aimed to evaluate the impact of biologic therapy on work productivity outcomes in an Italian real-life cohort of biologic-naïve patients with active…”
Get more information
Journal Article -
7
-
8